Immunological and Diagnostic Features of Pulmonary Tuberculosis with Allergic Bronchitis
DOI:
https://doi.org/10.52783/jns.v14.3034Keywords:
Tuberculosis, allergic bronchitis, pulmonary hypertension, immunological response, diagnostic methods, cytokine imbalance, treatment outcomesAbstract
Patients with pulmonary tuberculosis (TB) often experience simultaneous presentation of chronic allergic bronchitis which creates difficulties for proper diagnosis and medical treatment. The immune response in TB incorporates Th1 elements but allergic bronchitis runs on Th2 mechanisms which results in systemic immune dysregulation. The widespread coexistence of these conditions in Central Asia currently lacks adequate scientific research about their immunological aspects along with diagnostic complexity. The research analyzed pulmonary hypertension patients with chronic allergic disease and tuberculosis from Khorezm Regional Multidisciplinary Hospital. The research team performed clinical tests alongside laboratory examinations and Computed Tomography imaging and Echocardiography procedures and immunological evaluations. Patients participated in the Seattle Questionnaire to gauge physical activity levels and emotional stability and professional adaptation before bosentan and sildenafil therapy and after conclusion of the study. The study revealed 10.5% of patients presented with pulmonary hypertension that mainly started from left ventricular dysfunction (78.7%) and respiratory disorders (9.7%). Patients with TB and allergic bronchitis had simultaneous inflammatory problems and disturbed cytokine levels which decreased the success of their therapy. The research showed a notable drop in physical activity levels together with emotional steadiness which demonstrated the necessity to develop better diagnostic methods for clinical purposes. The correct diagnosis of TB and allergic bronchitis requires specific immunological strategies and enhancement of therapeutic strategies. The medical use of Bosentan along with sildenafil showed success in treating pulmonary hypertension but immune-modulating therapies need to be systematically implemented. The study shows that diagnostic protocols must incorporate immunological markers to achieve better disease separation and treatment success. Researchers need to develop individualized therapeutic approaches to address patients who suffer from both TB and allergic bronchitis
Downloads
Metrics
References
Tabyshova, A., Emilov, B., Postma, M. J., Chavannes, N. H., Sooronbaev, T., & van Boven, J. F. (2020). Prevalence and economic burden of respiratory diseases in central Asia and Russia: a systematic review. International Journal of Environmental Research and Public Health, 17(20), 7483.
Zheng, C., Hu, M., & Gao, F. (2017). Diabetes and pulmonary tuberculosis: a global overview with special focus on the situation in Asian countries with high TB-DM burden. Global health action, 10(1), 1264702.
Babamuradov, B., Trusov, A., Sianozova, M., & Zhandauletova, Z. (2017). Reducing TB among central Asia labor migrants. Health Affairs, 36(9), 1688-1688.
Guerrieri, M., Bargagli, E., Cassai, L., Gangi, S., Genovese, M., Viani, M., & Melani, A. S. (2024). Pulmonary tuberculosis in non-hiv adults: an evergreen old-fashioned disease in high-income countries. A narrative review. Expert Review of Respiratory Medicine, 18(11), 861-872.
Patil, S., & Patil, R. (2018). “Fleeting pulmonary infiltrates in allergic bronchopulmonary aspergillosis” Misdiagnosed as tuberculosis. The International Journal of Mycobacteriology, 7(2), 186-190.
Zavala, M. J., Becker, G. L., & Blount, R. J. (2023). Interrelationships between tuberculosis and chronic obstructive pulmonary disease. Current opinion in pulmonary medicine, 29(2), 104-111.
Torrelles, J. B., & Schlesinger, L. S. (2017). Integrating lung physiology, immunology, and tuberculosis. Trends in microbiology, 25(8), 688-697.
Polverino, E., Dimakou, K., Hurst, J.R., Martínez-García, M.A., Miravitlles, M., Paggiaro, P., Shteinberg, M., Aliberti, S., & Chalmers, J.D. (2018). The overlap between bronchiectasis and chronic airway diseases: state of the art and future directions. European Respiratory Journal, 52.
Kuruvilla, M. E., Lee, F. E. H., & Lee, G. B. (2019). Understanding asthma phenotypes, endotypes, and mechanisms of disease. Clinical reviews in allergy & immunology, 56, 219-233.
Poh, T. Y., Mac Aogáin, M., Chan, A. K. W., Yii, A. C. A., Yong, V. F. L., Tiew, P. Y., ... & Chotirmall, S. H. (2017). Understanding COPD-overlap syndromes. Expert review of respiratory medicine, 11(4), 285-298.
Shrimanker, R., Choo, X. N., & Pavord, I. D. (2017). A new approach to the classification and management of airways diseases: identification of treatable traits. Clinical Science, 131(10), 1027-1043.
Romagnani, S. (2004). The increased prevalence of allergy and the hygiene hypothesis: missing immune deviation, reduced immune suppression, or both?. Immunology, 112(3), 352-363.
Beyers, A. D., van Rie, A., Adams, J., Fenhalls, G., Gie, R., & Beyers, N. (1998, October). Signals that regulate the host response to Mycobacterium tuberculosis. In Genetics and Tuberculosis: Novartis Foundation Symposium 217 (pp. 145-159). Chichester, UK: John Wiley & Sons, Ltd.
Abebe, F. (2019). Synergy between Th1 and Th2 responses during Mycobacterium tuberculosis infection: A review of current understanding: The paper discusses the importance of simultaneous induction of Th1/Th2 responses to design and develop vaccine against TB. International Reviews of Immunology, 38(4), 172-179.
Menon, J., Hoeppner, V. H., Judd, A., Power, C. A., & Bretscher, P. A. (2018). A hypothesis for the existence of two types of tuberculosis, reflecting two distinct types of immune failure to control the pathogen, based upon prevalence of mycobacterium‐specific IgG subclasses. Scandinavian Journal of Immunology, 87(6), e12665.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
